Stock AnalyzerWatchlist Trades Portfolio Journal Screener Settings

Loading…

Novo Nordisk A/S

NVO · NYQ · Financials · Verdict · News · Trade plan · Forecast · Analysts & technicals · Options · AI analysis

Price

40 USD

close · 30.10.2026 (America/New_York)

Change vs previous close

+2.2%

Data: partial

ADR: P/B and multiples by year unavailable (receipt ≠ share)

Valuation · Reporting currency: DKK

P/E

9.8

P/S

3.6

EV/EBITDA

—

FCF yield

+3.2%